HROWHarrow Health, Inc.

$1B

Q2 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$23M+28.6% YoY

Gross Profit

$17M72.0% margin

Operating Income

$2M7.2% margin

Net Income

-$6M-26.8% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

+5.4%

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

$5M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$98M

Total Liabilities

$93M

Stockholders' Equity

$6M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23M	$18M	+28.6%
Gross Profit	$17M	$14M	+22.4%
Operating Income	$2M	$4M	-59.5%
Net Income	-$6M	-$2M	-151.8%

Revenue Segments

Other Revenues

$2M100%

HROW Q2 2022 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena